Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$7.76 - $10.23 $45,737 - $60,295
-5,894 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$9.11 - $10.96 $53,694 - $64,598
5,894 New
5,894 $59,000
Q1 2019

May 10, 2019

SELL
$7.89 - $12.23 $5,183 - $8,035
-657 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$7.29 - $15.27 $1,144 - $2,397
157 Added 31.4%
657 $5,000
Q3 2018

Nov 13, 2018

BUY
$5.82 - $17.47 $2,910 - $8,735
500 New
500 $9,000

Others Institutions Holding CSBR

About CHAMPIONS ONCOLOGY, INC.


  • Ticker CSBR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,522,400
  • Market Cap $53.7M
  • Description
  • Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...
More about CSBR
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.